News
Cover Media US on MSN23m
Low Doses of CBD Could Harm Liver, New FDA Study ShowsA new clinical trial raises concerns about the safety of low doses of cannabidiol (CBD), even as CBD products continue to ...
Around 5% of healthy adults exposed to cannabidiol show elevated liver enzyme levels exceeding the normal threshold alongside ...
Cannabidiol, a naturally occurring chemical found in marijuana plants, is “not likely to be abused or create dependence,” an initial review by the WHO’s Expert Committee on Drug Dependence ...
2d
HealthDay on MSNIncreased Liver Enzyme Levels Seen With Use of Cannabidiol in AdultsUse of cannabidiol (CBD) within the range consumers are taking with unregulated CBD products is associated with increased liver enzyme levels.
A mom who almost lost her job for failing a drug test after taking "THC free" CBD gummies is campaigning for mandatory ...
The global cannabidiol market size was US$ 5.1 billion in 2021. The global cannabidiol market is expected to grow to US$ 18.1 billion by 2030 by registering a compound annual growth rate (CAGR) of ...
Adolescent vaping of delta-9-tetrahydrocannabinol, cannabidiol, and synthetic cannabinoids increased significantly from 2021 to 2023.
Cannabidiol is one of more than 100 chemicals called cannabinoids that can be distilled from Cannabis plants, which include both marijuana and hemp.
In vitro tests indicate that cannabidiol can stimulate the biomineralization of teeth even under inflammatory conditions, ...
Study: Cannabidiol, a plant-derived compound, is an emerging strategy for treating cognitive impairments: comprehensive review of randomized trials.Image Credit: Creativan / Shutterstock. An ...
Cannabidiol Market Growth. Key Takeaway. Market Growth: The global cannabidiol (CBD) market reached USD 7.6 billion in 2023 and is projected to surge to approximately USD 36.6 billion by 2033 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results